A phase II study of docetaxel and carboplatin with concurrent radiation therapy for locally advanced head and neck cancer

Auris Nasus Larynx

Volumn 38, Issue 1, 2011, Pages 108-113

  Chitapanarux, Imjai ^a   Lorvidhaya, Vicharn ^a   Tharavichitkul, Ekasit ^a   Mayurasakorn, Somvilai ^a   Sittitrai, Pichit ^b   Pattarasakulchai, Tienchai ^b   Tananuwat, Rak ^b   Srivanitchapoom, Chonticha ^b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Carboplatin; Chemoradiotherapy; Docetaxel; Head and neck cancer; Phase II study

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DOCETAXEL;

ADULT; AGED; ALLERGIC REACTION; ALVEOLAR RIDGE; ANEMIA; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CHEEK MUCOSA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DERMATITIS; DISEASE ACTIVITY; DISEASE COURSE; DISEASE FREE SURVIVAL; DRUG ERUPTION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; LARYNX CANCER; MALE; MAXILLA SINUS CANCER; MOUTH CANCER; MUCOSA INFLAMMATION; NEPHROTOXICITY; NEUTROPENIA; OPEN STUDY; OROPHARYNX CANCER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; RADIATION DOSE; THROMBOCYTOPENIA; TONGUE; TONSIL; TREATMENT REFUSAL; URTICARIA; WHEEZING; XEROSTOMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TAXOIDS; TREATMENT OUTCOME;

EID: 78651295832     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2010.05.012     Document Type: Article

References (22)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001, 94:153-156.
2. Voravud N., Charuruks N., Mutirangura A. Squamous cell carcinoma of head and neck. J Med Assoc Thai 1997, 80:207-218.
3. Nimit M, Nilubol P. Cancer incidence and leading sites. In: Hutcha S, editor. Cancer in Thailand 1995-1997, vol. III; 2003. p. 9-18.
4. Vokes E.E., Weichselbaum R.R., Lippman S.M. Head and neck cancer. N Engl J Med 1993, 328:184-194.
5. Schwartz D.L., Montgomery R.B., Yueh B., Donahue M., Anzai Y., Canby R., et al. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 2005, 103:2534-2543.
6. Brizel D.M., Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum. J Clin Oncol 2006, 24:2612-2617.
7. Fountzilas G., Skarlos D., Nikolaou A., Kalogera-Fountzila A., Tzitzikas J., Kosmidis P., et al. Radiation and concurrent carboplatin administration in locally advanced head and neck cancer. A Hellenic Cooperative Oncology Group Study. Tumori 1995, 81:354-358.
8. Jeremic B., Shibamoto Y., Stanisavljevic B., Milojevic L., Milicic B., Nikolic N. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. Radiother Oncol 1997, 43:29-37.
9. Kim E.S., Khuri F.R. Docetaxel and radiation as combined-modality therapy. Oncology (Williston Park) 2002, 16(Suppl. 6):97-105.
10. Hanauske A.R., Degen D., Hilsenbeck S.G., Bissery M.C., Von Hoff D.D. Effects of taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells. Anticancer Drugs 1992, 3:121.
11. Von Hoff D.D. The taxoids: same roots, different drugs. Semin Oncol 1997, 24(Suppl. 13):3-10.
12. Hesse K., Heinrich B., Zimmermann F., Kau R., Sommer G., Achterrath W., et al. Combined radiochemotherapy with docetaxel in patients with unresectable locally advanced head and neck tumors. Strahlenther Onkol 2000, 176:67-72.
13. Tishler R., Colevas A.D., Norris C.M., Lamb C., Nixon A., Lake-Willcutt B., et al. A phase I/II trial of concurrent docetaxel (T) and once daily radiation following induction chemotherapy in squamous cell cancer of the head and neck. Proc Am Soc Clin Oncol 2001, 20:233a. [Abstract 930].
14. Fujii M., Tsukuda M., Satake B., Kubota A., Kida A., Kohno N., et al. Japan Cooperative Head and Neck Oncology Group (JCHNOG). Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck. Int J Clin Oncol 2004, 9:107-112.
15. Calais G., Bardet E., Sire C., Alfonsi M., Bourhis J., Rhein B., et al. Radiotherapy with concomitant weekly docetaxel for stage III/IV oropharynx carcinoma. Results of the 98-02 GORTEC phase II trial. Int J Radiat Oncol Biol Phys 2004, 58:161-166.
16. Schwartz D.L., Yueh B., Montgomery R.B., Donahue M., Canby R., Anzai Y., et al. A phase I/II trial investigating weekly docetaxel and carboplatin (DC) given neoadjuvantly and then concurrently with concomitant boost radiotherapy (CB-XRT) for locally advanced squamous cell carcinoma of the head and neck. Proc Am Soc Clin Oncol 2003, 22:506. [Abstract 2038].
17. Karasawa K., Shinoda H., Katsui K., Seki K., Kohno M., Hanyu N., et al. Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer. Anticancer Res 2002, 22(6B):3785-3788.
18. Kucukzeybek Y., Gorumlu G., Karaca B., Erten C., Cengiz E., Kemal Gul M., et al. Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer. J BUON 2008, 13:199-203.
19. Samlowski W.E., Moon J., Kuebler J.P., Nichols C.R., Gandara D.R., Ozer H., et al. Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study. Cancer Invest 2007, 25:182-188.
20. Seiwert T.Y., Salama J.K., Vokes E.E. The chemoradiation paradigm in head and neck cancer. Nat Clin Pract Oncol 2007, 4:156-171.
21. Saba N.F., Edelman S., Tighiouart M., Gaultney J., Davis L.W., Khuri F.R., et al. Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head Neck 2009, 31:1447-1455.
22. Cmelak A.J., Murphy B.A., Burkey B., Douglas S., Shyr Y., Netterville J. Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: results of a phase II multi-institutional trial. Head Neck 2007, 29:315-324.